Afya Reports Strong 2025 Financials, Declares Significant Dividend, and Optimizes Capital Structure with SoftBank Preferred Share Repurchase

summarizeSummary

Afya Ltd reported strong 2025 financial results, including significant revenue and net income growth. The company announced a substantial dividend, repurchased all SoftBank preferred shares, and authorized a new share buyback program, while also addressing regulatory changes and new tax impacts.

check_boxKey Events

• Strong 2025 Financial Performance

  Reported revenue of R$3,697.3 million (+11.9%), net income of R$768.4 million (+18.4%), and basic EPS of R$8.32 (+18.7%) for the year ended December 31, 2025.

• Significant Dividend Declared

  The Board of Directors approved a dividend distribution of R$307.4 million, representing 40% of the consolidated net income for 2025, payable on April 6, 2026.

• SoftBank Preferred Share Repurchase and Cancellation

  Repurchased and cancelled all R$831.6 million (equivalent to approximately US$151 million) outstanding Series A perpetual convertible preferred shares from SoftBank on November 3, 2025.

• New Share Repurchase Program Authorized

  Approved a new program on August 13, 2025, to repurchase up to 4,000,000 Class A common shares by December 31, 2026. The company repurchased 966,541 Class A common shares in 2025.

auto_awesomeAnalysis

Afya Ltd's annual report highlights robust financial performance for 2025, marked by double-digit growth in revenue, net income, and EPS. The company demonstrated a strong commitment to shareholder returns by declaring a substantial dividend and initiating a new share repurchase program. A significant capital structure optimization occurred with the repurchase and cancellation of all Series A perpetual convertible preferred shares from SoftBank. While the cancellation of the Mais Médicos III program presents a potential headwind for future organic growth in medical school seats, and the new Pillar Two global minimum tax introduced a material additional tax expense, the company is actively managing these challenges through legal proceedings and strategic adjustments. The overall picture is one of a growing company with solid financial health, making strategic capital allocation decisions.